Skip to content

SELLAS Life Sciences Group, Inc. SLS Return on invested capital

Return on invested capital at other companies

Pfizer logo
PfizerPFE
6%
Syndax Pharmaceuticals logo
Syndax PharmaceuticalsSNDX
-67.9%-12.9pp
AbbVie logo
AbbVieABBV
17.1%
Immunome logo
ImmunomeIMNM
-746.6%+212pp
Arcus Biosciences logo
Arcus BiosciencesRCUS
-95.3%+1.8pp
Cogent Biosciences, Inc. logo
Cogent Biosciences, Inc.COGT
-147.2%-18.7pp

Other financials

Income statement

See full
Revenue-
Gross profit-
Operating income-$9.3M-52.6%
Net income-$8.4M-44.6%
EPS (diluted)-$0.05+28.6%

Balance sheet

See full
Cash & equivalents$107.1M+277%
Total debt$871.0K+0.1%
Total equity$107.4M+287%
Total assets$114.2M+227%

Cash flow

See full
Operating cash flow-$8.8M+2.5%

Valuation

See full
Market cap$1.78B+674%
Enterprise value$1.68B+826%

Profitability

See full
Gross margin90%-7.4pp
Operating margin-4,195%-4,591pp
Net margin-4,130.1%-4,444pp
FCF margin-300.5%

Returns & leverage

See full
Return on equity-43.6%-17.9pp
Debt / equity0.0×
Current ratio17.2×+12.6×

Where this comes from

Calculated from SELLAS Life Sciences Group, Inc.’s reported figures.

Based on trailing twelve months.

The official record: SELLAS Life Sciences Group, Inc.’s 10-Q, filed May 12, 2026, on SEC EDGAR. View the filing →

Ask your AI about SELLAS Life Sciences Group, Inc.'s return on invested capital.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is SELLAS Life Sciences Group, Inc.'s return on invested capital?
SELLAS Life Sciences Group, Inc. (SLS) reported return on invested capital of -4,437.7% in Q1 2026.
What does return on invested capital mean?
Net operating profit after tax (operating income taxed at the effective rate) divided by average invested capital (debt plus equity minus cash). Measures the after-tax return on all capital put to work in the business, independent of capital structure.